Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,018 | 12,032 | -4,301 | -11,992 | N/A |
| Depreciation Amortization | 738 | 705 | 786 | 1,132 | N/A |
| Accounts receivable | 209 | -76 | 11,230 | -11,008 | N/A |
| Other Working Capital | -14,256 | -16,675 | 47,418 | -3,266 | N/A |
| Other Operating Activity | 557 | 692 | -9,560 | 11,445 | 0 |
| Operating Cash Flow | $266 | $-3,322 | $45,573 | $-13,689 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,715 | -11,326 | 1,010 | 14,179 | N/A |
| PPE Investments | -1,529 | -146 | -519 | -280 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -10 | 0 |
| Investing Cash Flow | $-3,244 | $-11,472 | $491 | $13,889 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,701 | N/A | N/A | N/A |
| Common Stock Issued | 42,657 | 49 | N/A | 2 | N/A |
| Other Financing Activity | -1,533 | -2,739 | 0 | 0 | 0 |
| Financing Cash Flow | $41,124 | $-4,391 | $N/A | $2 | $N/A |
| Exchange Rate Effect | -4,070 | -3,027 | 170 | -314 | N/A |
| Beginning Cash Position | 37,950 | 60,162 | 13,928 | 14,040 | N/A |
| End Cash Position | 72,026 | 37,950 | 60,162 | 13,928 | N/A |
| Net Cash Flow | $34,076 | $-22,212 | $46,234 | $-112 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 266 | -3,322 | 45,573 | -13,689 | N/A |
| Capital Expenditure | -1,529 | -156 | -526 | -290 | N/A |
| Free Cash Flow | -1,263 | -3,478 | 45,047 | -13,979 | 0 |